tim@emorningcoffee.comNov 2711 min readA quick look at MicroStrategy (MSTR)MicroStrategy (MSTR) has had an amazing run since it adopted its Bitcoin accumulation strategy in Aug 2020. Has it run too far too fast?
tim@emorningcoffee.comMar 188 min readAnti-obesity medications: part 3, valuations of LLY and NVOThis is the 3rd and final article focused on anti-obesity drugs. It looks at valuations of shares of the two giants in this biz, LLY & NVO.
tim@emorningcoffee.comMar 147 min readAnti-obesity medications part 2: the duopoly of Eli Lilly and Novo NordiskEli Lilly (LLY) and Novo Nordisk (NVO) have been large players for decades in the market for diabetes medications and are currently...
tim@emorningcoffee.comMar 127 min readAnti-obesity medications part 1: the market for anti-obesity drugsThis article is being published in instalments, of which this is the first, for context. INTRODUCTION Two macrotrends have been drivers...
tim@emorningcoffee.comFeb 279 min readBerkshire Hathaway: 2023 results and the path forwardBerkshire Hathaway released its FY earnings on Sat. As always, there are plenty of juicy nuggets to digest.
tim@emorningcoffee.comFeb 205 min readRevisiting semi-conductorsThis article takes a quick look at the semi-conductor value-chain, including chip designers, fabricators and chip machinery makers.
tim@emorningcoffee.comMar 13, 202312 min readThe end of Silicon Valley BankSilicon Valley Bank went from fine to dead in less than 48 hours. Why and how? Could it have been prevented? What now?
tim@emorningcoffee.comSep 22, 20226 min readTesla: as resilient as everLove it or hate it, the fact is that Tesla's stock performance has left nearly all peers – tech and automotive – in the dust. Now what?
tim@emorningcoffee.comAug 30, 20229 min readRevisiting Saudi Aramco Saudi Aramco did a much-watched IPO in Dec 2019. This article looks at the performance of the shares since the IPO (and other IOCs).